Top

Tag: Aspen Neuroscience


Cell and Gene Therapy, Industry

Investors take root in Aspen Neuroscience’s customized cell therapy as $147.5M round closes

May 9, 2022

Via: FierceBiotech

Aspen Neuroscience, a biotech developing the first autologous neuron replacement for Parkinson’s disease, is seeing double, as investors have flooded the company’s series B with $147.5 million following an initial $70 million round two years ago. The private neurodegenerative disease […]